RGC

Regencell Bioscience Holdings
RGC

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$4.46B
EV
$4.46B
Shares Outstanding
13.74M
Beta
-4.39

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E undefinedE
-
P/Revenue undefinedE
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Regencell Bioscience Holdings Limited

gainify
RGC

Regencell Bioscience Holdings Limited

RGC

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, prima...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Au, Yat-Gai

Employees

12

IPO Date

2021-07-16

Headquarters

Chinachem Leighton Plaza, 9th Floor, 29 Leighton Road, Causeway Bay Hong Kong

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on Instagram
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.